Showing 1 - 20 results of 51,581 for search '(( 50 ((mean decrease) OR (a decrease)) ) OR ((( _ red decrease ) OR ( _ stem decrease ))))*', query time: 1.01s Refine Results
  1. 1
  2. 2

    Comparison of mean differences in temperature decreases. by Hans-Jörg Gillmann (8460585)

    Published 2022
    “…<p>Patients are grouped according to receiving either dipyrone (blue; n = 341) or acetaminophen (red; n = 71) versus patients receiving no antipyretic treatment (n = 315). …”
  3. 3

    Decreased ISCs and increased goblet cells after intestinal specific loss of MLL1. by Neha Goveas (11790822)

    Published 2021
    “…Scale bars are 100 μm for OLFM4 and 50 μm for SOX9 and Ki67. (D) Left panels; alcian blue staining of goblet cells with nuclear fast red (NFR) to stain nuclei. …”
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17

    TMD residues decrease sensitivity. by Ákos Nemecz (356830)

    Published 2017
    “…Glu residues are color coded based upon effect, with residues in red producing a significant decrease in pH<sub>50</sub>, and in yellow, an insignificant or weak effect, whereas the dark purple and magenta for His residues are synonymous to the red of Glu residues. …”
  18. 18
  19. 19

    Image_2_Red blood cells from patients with sitosterolemia exhibit impaired membrane lipid composition and distribution and decreased deformability.jpeg by Anne-Sophie Cloos (9082913)

    Published 2023
    “…However, the impact of phytosterols on red blood cell (RBC) deformability, membrane lipid composition and distribution and the efficiency of the reference treatment, Ezetimibe, are largely unknown. …”
  20. 20

    Image_1_Red blood cells from patients with sitosterolemia exhibit impaired membrane lipid composition and distribution and decreased deformability.jpeg by Anne-Sophie Cloos (9082913)

    Published 2023
    “…However, the impact of phytosterols on red blood cell (RBC) deformability, membrane lipid composition and distribution and the efficiency of the reference treatment, Ezetimibe, are largely unknown. …”